We are live on ! Find out more
FENC icon

Fennec Pharmaceuticals
FENC

55 hedge funds and large institutions have $116M invested in Fennec Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 18 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

540% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 5

350% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 4

106% more capital invested

Capital invested by funds: $56.3M → $116M (+$59.6M)

90% more funds holding

Funds holding: 29 → 55 (+26)

7.1% more ownership

Funds ownership: 47.6% → 54.7% (+7.1%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more call options, than puts

Call options by funds: $273K | Put options by funds: $273K

Holders
55
Holders Change
+26
Holders Change %
+89.66%
% of All Funds
1.13%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
32
Increased
18
Reduced
4
Closed
5
Calls
$273K
Puts
$273K
Net Calls
–
Net Calls Change
-$115K

Top Buyers

1
BlackRock
BlackRock
New York
+$7.7M
2
SFI
Sonic Fund II
Hawaii
+$5.95M
3
ACA
Avoro Capital Advisors
New York
+$4.19M
4
EAM
Eventide Asset Management
Massachusetts
+$2.97M
5
State Street
State Street
Massachusetts
+$2.1M

Top Sellers

1
GIM
Granahan Investment Management
Massachusetts
-$185K
2
Millennium Management
Millennium Management
New York
-$114K
3
Victory Capital Management
Victory Capital Management
Texas
-$110K
4
WQ
Wealth Quarterback
New Jersey
-$5.94K
5
MAM
Meeder Asset Management
Ohio
-$3.94K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCA
1
Southpoint Capital Advisors
New York
$34M +$595K +80,000 +2%
ACA
2
Avoro Capital Advisors
New York
$13.9M +$4.19M +564,001 +51%
SFI
3
Sonic Fund II
Hawaii
$13.7M +$5.95M +800,000 +96%
EAM
4
Eventide Asset Management
Massachusetts
$9.35M +$2.97M +400,000 +56%
6CM
5
683 Capital Management
New York
$9.27M +$1.19M +160,000 +17%
BlackRock
6
BlackRock
New York
$8.93M +$7.7M +1,035,798 +3,095%
SCM
7
Solas Capital Management
Connecticut
$8.02M – – –
State Street
8
State Street
Massachusetts
$2.35M +$2.1M +281,868 New
GIM
9
Granahan Investment Management
Massachusetts
$2.05M -$185K -24,832 -9%
Northern Trust
10
Northern Trust
Illinois
$1.81M +$1.61M +216,860 New
OM
11
Opaleye Management
Massachusetts
$1.43M +$1.27M +171,000 New
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$1.33M +$524K +70,430 +80%
CCM
13
Cadence Capital Management
Massachusetts
$1.28M +$48K +6,448 +4%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$1.25M +$1.12M +150,200 New
Renaissance Technologies
15
Renaissance Technologies
New York
$1.12M +$431K +57,904 +76%
Vanguard Group
16
Vanguard Group
Pennsylvania
$754K +$671K +90,264 New
N
17
Nuveen
North Carolina
$633K +$564K +75,810 New
HFM
18
Hartford Financial Management
Connecticut
$414K +$55K +7,400 +18%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$404K +$360K +48,439 New
Charles Schwab
20
Charles Schwab
California
$389K +$346K +46,584 New
Bank of America
21
Bank of America
North Carolina
$305K +$207K +27,882 +322%
California State Teachers Retirement System (CalSTRS)
22
California State Teachers Retirement System (CalSTRS)
California
$272K +$242K +32,568 New
WS
23
Wedbush Securities
California
$270K +$60.2K +8,100 +33%
Goldman Sachs
24
Goldman Sachs
New York
$255K +$121K +16,337 +115%
WMSA
25
Weiss Multi-Strategy Advisers
New York
$210K -$2.35K -316 -1%
1
2 3

FENC Hedge Fund Activity: Q2 2020 in Review

55 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Fennec Pharmaceuticals (FENC) for Q2 2020, worth a combined $116M — up 106% from $56.3M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new FENC positions and 5 closed out — a net gain of 27 holders — while 18 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $7.7M. The largest seller was Granahan Investment Management, cutting an estimated $185K.

  • 55 institutional investors held Fennec Pharmaceuticals (FENC) as of Q2 2020, up from 29 in Q1 2020.
  • Funds reported $116M of Fennec Pharmaceuticals stock for Q2 2020, up 106% quarter-over-quarter.
  • 32 funds opened new Fennec Pharmaceuticals positions in Q2 2020 and 5 closed out, a net change of +27 holders.
  • The largest Fennec Pharmaceuticals buyer in Q2 2020 was BlackRock, an estimated $7.7M added.
  • The largest Fennec Pharmaceuticals seller in Q2 2020 was Granahan Investment Management, an estimated $185K sold.

Based on aggregated 13F filings for Q2 2020.